Posted by Michael Wonder on 30 Sep 2021
NICE terminates another two appraisals
29 September 2021 - Four terminations for the month.
NICE has terminated the following appraisals:
- Avapritinib for treatment of patients with a unresectable or metastatic gastro-intestinal stromal tumour
- Vericiguat for the treatment of patients with chronic heart failure with reduced ejection fraction
